Correlated with larger tumors, retroperitoneal invasion, lymph node metastasis, and worse survival outcomes by inducing CXCL1 secretion and immunosuppressive microenvironment. This evidence concerns the gene CXCL1 and metastatic malignant neoplasm in the lymph nodes.